WO2001075179A3 - Preprocalcitonin as tumor rejection antigen precursor and uses thereof - Google Patents
Preprocalcitonin as tumor rejection antigen precursor and uses thereof Download PDFInfo
- Publication number
- WO2001075179A3 WO2001075179A3 PCT/US2001/040288 US0140288W WO0175179A3 WO 2001075179 A3 WO2001075179 A3 WO 2001075179A3 US 0140288 W US0140288 W US 0140288W WO 0175179 A3 WO0175179 A3 WO 0175179A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tumor rejection
- rejection antigen
- preprocalcitonin
- antigen precursor
- precursor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001253852A AU2001253852A1 (en) | 2000-03-31 | 2001-03-14 | Preprocalcitonin as tumor rejection antigen precursor and uses thereof |
EP01927400A EP1301624A2 (en) | 2000-03-31 | 2001-03-14 | Preprocalcitonin as tumor rejection antigen precursor and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53956700A | 2000-03-31 | 2000-03-31 | |
US09/539,567 | 2000-03-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001075179A2 WO2001075179A2 (en) | 2001-10-11 |
WO2001075179A3 true WO2001075179A3 (en) | 2003-02-06 |
Family
ID=24151778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/040288 WO2001075179A2 (en) | 2000-03-31 | 2001-03-14 | Preprocalcitonin as tumor rejection antigen precursor and uses thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1301624A2 (en) |
AU (1) | AU2001253852A1 (en) |
WO (1) | WO2001075179A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008504850A (en) * | 2004-06-16 | 2008-02-21 | アフィナジー, インコーポレイテッド | IFBM for promoting specific adhesion of a target analyte to the surface of an orthopedic implant |
EP2006384A1 (en) * | 2007-06-22 | 2008-12-24 | Institut Gustave Roussy | Preprocalcitonin-derived antigen epitopes |
US20130046085A1 (en) * | 2011-06-22 | 2013-02-21 | Universidad De Sevilla | Antibodies against n-procalcitonin |
EP3115058A1 (en) | 2015-07-09 | 2017-01-11 | Institut Gustave Roussy | Immunogenic preprocalcitonin peptides |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0520794A1 (en) * | 1991-06-26 | 1992-12-30 | F. Hoffmann-La Roche Ag | Methods for detection of carcinoma metastases by nucleic acid amplification |
WO1997025622A1 (en) * | 1996-01-12 | 1997-07-17 | B.R.A.H.M.S. Diagnostica Gmbh | Diagnostic method for determining the etiology of inflammatory processes |
WO1998033524A1 (en) * | 1997-02-03 | 1998-08-06 | Endocrinology Associates-Australia Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
-
2001
- 2001-03-14 AU AU2001253852A patent/AU2001253852A1/en not_active Abandoned
- 2001-03-14 EP EP01927400A patent/EP1301624A2/en not_active Withdrawn
- 2001-03-14 WO PCT/US2001/040288 patent/WO2001075179A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0520794A1 (en) * | 1991-06-26 | 1992-12-30 | F. Hoffmann-La Roche Ag | Methods for detection of carcinoma metastases by nucleic acid amplification |
WO1997025622A1 (en) * | 1996-01-12 | 1997-07-17 | B.R.A.H.M.S. Diagnostica Gmbh | Diagnostic method for determining the etiology of inflammatory processes |
WO1998033524A1 (en) * | 1997-02-03 | 1998-08-06 | Endocrinology Associates-Australia Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
Non-Patent Citations (6)
Title |
---|
EDBROOKE M R ET AL: "EXPRESSION OF THE HUMAN CALCITONIN-CALCITONIN GENE RELATED PEPTIDE GENE IN LUNG AND THYROID CARCINOMA", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 4, no. 3, 1985, pages 715 - 724, XP008003708, ISSN: 0261-4189 * |
ICHIKI S ET AL: "PRODUCTION OF IMMUNOREACTIVITY CALCITONIN AND SOME OTHER TUMOR MARKERS BY ESTABLISHED HUMAN CARCINOMA CELL LINES", JAPANESE JOURNAL OF CANCER RESEARCH, vol. 77, no. 3, 1986, pages 270 - 275, XP008003477, ISSN: 0910-5050 * |
KELLEY MICHAEL J ET AL: "Small cell lung carcinoma cell lines express mRNA for calcitonin and alpha- and beta-calcitonin gene related peptides.", CANCER LETTERS, vol. 81, no. 1, 1994, pages 19 - 25, XP008003713, ISSN: 0304-3835 * |
LUSTER W ET AL: "DEMONSTRATION OF IMMUNO REACTIVE CALCITONIN IN SERA AND TISSUES OF LUNG CANCER PATIENTS", EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, vol. 18, no. 12, 1982, pages 1275 - 1284, XP008003714, ISSN: 0277-5379 * |
TAKANO TORU ET AL: "Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy.", JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 84, no. 3, March 1999 (1999-03-01), pages 951 - 955, XP002200565, ISSN: 0021-972X * |
WHANG KEVIN T ET AL: "Serum calcitonin precursors in sepsis and systemic inflammation.", JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 83, no. 9, 1998, pages 3296 - 3301, XP002200569, ISSN: 0021-972X * |
Also Published As
Publication number | Publication date |
---|---|
AU2001253852A1 (en) | 2001-10-15 |
WO2001075179A2 (en) | 2001-10-11 |
EP1301624A2 (en) | 2003-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001233027A1 (en) | Antibodies against ctla4 (cd152), conjugates comprising same, and uses thereof | |
WO2001047959A3 (en) | Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof | |
WO2005010048A3 (en) | Rg1 antibodies and uses thereof | |
EP1293503A4 (en) | Triazole derivatives | |
WO2002024149A3 (en) | Immunogen comprising ligand bound hiv envelpe protein | |
WO2002042422A3 (en) | Molecular interactions in hematopoietic cells | |
AU2001244609A1 (en) | Novel protein, dna thereof and process for producing the same | |
WO1999064464A3 (en) | Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means | |
WO1997029199A3 (en) | Prostate specific antigen peptides and uses thereof | |
AU2001295483A1 (en) | Solid peptide preparations for inhalation, and the production thereof | |
EP1128162A3 (en) | Navigation device | |
WO2001075179A3 (en) | Preprocalcitonin as tumor rejection antigen precursor and uses thereof | |
HK1054202A1 (en) | Orally disintegrating solid preparations and processes for the production thereof. | |
AU2002365269A1 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
WO2002047613A3 (en) | Immunogenic cancer peptides and uses thereof | |
ZA971403B (en) | Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof. | |
AU4990999A (en) | Survivin, and peptides thereof, as an anti-cancer vaccine | |
WO2002026785A3 (en) | Epitopes of virus hepatitis c specifically cd4+ t lymphocytes | |
HUP0202270A2 (en) | Antitumor antibodies, proteins, and uses thereof | |
WO2003057693A1 (en) | 5-membered cyclic compounds | |
WO2003018629A8 (en) | Cage antigen | |
WO2001097771A3 (en) | Preparations that contain an extract of the plant pistia stratiotes | |
AU2002365925A1 (en) | Rsv proteins, antibodies, compositions, methods and uses | |
WO2001077155A3 (en) | Orfx polynucleotides and polypeptides | |
WO2002088740A3 (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CN JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001927400 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001927400 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001927400 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |